Skip to main content
. 2013 Dec 15;4(6):358–364. doi: 10.4239/wjd.v4.i6.358

Figure 1.

Figure 1

Glycosylated hemoglobin A1c changes from pre- to post-Ramadan period (A) and percentage of patients who achieved target glycosylated hemoglobin A1c < 7.0% (B). aP < 0.05, bP = 0.009. Vildagliptin group: Patients receiving vildagliptin ± metformin; Sulfonylurea group: Patients receiving sulfonylurea ± metformin; HbA1c: Glycosylated hemoglobin A1c.